Scheinman M
Cardiol Clin. 1986 Aug;4(3):543-50.
Catheter ablative techniques have introduced an exciting new chapter of interventional therapy for patients with drug-resistant cardiac arrhythmias. A variety of techniques are presently available, and proper choice depends on proper localization of the tachycardia focus and mechanism of the arrhythmia. These techniques should be performed only in laboratories with personnel experienced in invasive electrophysiologic procedures. Over the past 5 years, we have learned that catheter ablation of the AV junction for patients with drug-resistant supraventricular tachycardia has replaced the need for surgery in these patients. In addition, preliminary experience suggests that the catheter technique may be highly effective for patients with tachycardia incorporating a posteroseptal accessory pathway. The precise role of catheter ablation for patients with atrial or ventricular tachycardia has not been clearly defined.
导管消融技术为耐药性心律失常患者开创了介入治疗的新篇章。目前有多种技术可供选择，正确的选择取决于心动过速起源点的准确定位和心律失常的机制。这些技术应仅在有经验丰富的侵入性电生理操作人员的实验室中进行。在过去5年中，我们了解到，对于耐药性室上性心动过速患者，导管消融房室结已取代了手术治疗。此外，初步经验表明，导管技术对于合并后间隔旁路的心动过速患者可能非常有效。导管消融在房性或室性心动过速患者中的精确作用尚未明确界定。
